Treatment Optimization in Patients With Untreated Multiple Myeloma

NCT02145598 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

85

Enrollment

OTHER

Sponsor class

Stopped Insufficient recruitment

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide
DRUG: Placebo

Sponsor

Dr. med. Lars-Olof Muegge